Achieve Life Sciences ACHV
NASDAQ ACHV
$7.53 -0.56 (-6.92%)
At close: Oct 1, 2026 · 4:00 PM EDT

Achieve Life Sciences (ACHV) Accumulated Expenses (2012 - 2026)

Updated

Achieve Life Sciences (ACHV) reported Accumulated Expenses of $200,000 for Q2 2026, down 2.4% from the prior quarter.

Analysis

Achieve Life Sciences (ACHV) Accumulated Expenses (2012 - 2026) Analysis & Trends

At the end of FY2025, Achieve Life Sciences posted Accumulated Expenses of $5,500.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Achieve Life Sciences 352.68 Mn 352.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 200,000.00
Mar 31, 2026 205,000.00
Dec 31, 2025 5,500.00
Sep 30, 2014 13.17 Mn
Jun 30, 2014 13.25 Mn
Mar 31, 2014 13.04 Mn
Dec 31, 2013 11.78 Mn
Sep 30, 2013 11.33 Mn
Jun 30, 2013 9.27 Mn
Dec 31, 2012 4.18 Mn
API Access

Achieve Life Sciences Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ACHV&period=max&api_key=YOUR_API_KEY